Of particular interest were the hypermethylation of DNMT3A, a DNA methylation writer, in five cancer types and TET2, a DNA methylation eraser, in four cancer types, suggesting a possible mechanism in which global DNA methylation changes may be effected via hypermethylation of these targets. The gene discussed is TET2; the disease is cancer.